Keywords
Last Name
Institution

CARMELITA P ESCALANTE

TitleProfessor
InstitutionMD Anderson
DepartmentGeneral Internal Medicine
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, Cleeland C, Dotan E, Eisenberger MA, Escalante CP, Jacobsen PB, Jankowski C, LeBlanc T, Ligibel JA, Loggers ET, Mandrell B, Murphy BA, Palesh O, Pirl WF, Plaxe SC, Riba MB, Rugo HS, Salvador C, Wagner LI, Wagner-Johnston ND, Zachariah FJ, Bergman MA, Smith C. Cancer-Related Fatigue, Version 2.2015. J Natl Compr Canc Netw. 2015 Aug; 13(8):1012-39. PMID: 26285247.
      View in: PubMed
    2. Yennurajalingam S, Reddy A, Tannir NM, Chisholm GB, Lee RT, Lopez G, Escalante CP, Manzullo EF, Frisbee Hume S, Williams JL, Cohen L, Bruera E. High-Dose Asian Ginseng (Panax Ginseng) for Cancer-Related Fatigue: A Preliminary Report. Integr Cancer Ther. 2015 Sep; 14(5):419-27. PMID: 25873296.
      View in: PubMed
    3. Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, Schnipper HH, Lacchetti C, Ligibel JA, Lyman GH, Ogaily MS, Pirl WF, Jacobsen PB. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol. 2014 Jun 10; 32(17):1840-50. PMID: 24733803.
      View in: PubMed
    4. Holmes HM, Nguyen HT, Nayak P, Oh JH, Escalante CP, Elting LS. Chronic conditions and health status in older cancer survivors. Eur J Intern Med. 2014 Apr; 25(4):374-8. PMID: 24389373.
      View in: PubMed
    5. Elting LS, Chang YC, Parelkar P, Boers-Doets CB, Michelet M, Hita G, Rouleau T, Cooksley C, Halm J, Vithala M, Bossi P, Escalante C, Brennan MT. Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis. Support Care Cancer. 2013 Nov; 21(11):3243-54. PMID: 23636648.
      View in: PubMed
    6. Vu K, Busaidy N, Cabanillas ME, Konopleva M, Faderl S, Thomas DA, O'Brien S, Broglio K, Ensor J, Escalante C, Andreeff M, Kantarjian H, Lavis V, Yeung SC. A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk. 2012 Oct; 12(5):355-62. PMID: 22658895; PMCID: PMC3974971.
    7. Levine MN, Gu C, Liebman HA, Escalante CP, Solymoss S, Deitchman D, Ramirez L, Julian J. A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer. J Thromb Haemost. 2012 May; 10(5):807-14. PMID: 22409262.
      View in: PubMed
    8. Zalpour A, Kroll MH, Afshar-Kharghan V, Yusuf SW, Escalante C. Role of factor xa inhibitors in cancer-associated thrombosis: any new data? Adv Hematol. 2011; 2011:196135. PMID: 22013445; PMCID: PMC3195274.
    9. Escalante CP, Zalpour A. Vascular endothelial growth factor inhibitor-induced hypertension: basics for primary care providers. Cardiol Res Pract. 2011; 2011:816897. PMID: 21629798; PMCID: PMC3099203.
    10. Mortimer JE, Barsevick AM, Bennett CL, Berger AM, Cleeland C, DeVader SR, Escalante C, Gilreath J, Hurria A, Mendoza TR, Rugo HS. Studying cancer-related fatigue: report of the NCCN scientific research committee. J Natl Compr Canc Netw. 2010 Dec; 8(12):1331-9. PMID: 21147900.
      View in: PubMed
    11. Connor TH, DeBord DG, Pretty JR, Oliver MS, Roth TS, Lees PS, Krieg EF, Rogers B, Escalante CP, Toennis CA, Clark JC, Johnson BC, McDiarmid MA. Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers. J Occup Environ Med. 2010 Oct; 52(10):1019-27. PMID: 20881620.
      View in: PubMed
    12. McDiarmid MA, Oliver MS, Roth TS, Rogers B, Escalante C. Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. J Occup Environ Med. 2010 Oct; 52(10):1028-34. PMID: 20881619.
      View in: PubMed
    13. Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP, Jacobsen PB, Kaldor P, Ligibel JA, Murphy BA, O'Connor T, Pirl WF, Rodler E, Rugo HS, Thomas J, Wagner LI. Cancer-related fatigue. J Natl Compr Canc Netw. 2010 Aug; 8(8):904-31. PMID: 20870636.
      View in: PubMed
    14. Escalante CP, Kallen MA, Valdres RU, Morrow PK, Manzullo EF. Outcomes of a cancer-related fatigue clinic in a comprehensive cancer center. J Pain Symptom Manage. 2010 Apr; 39(4):691-701. PMID: 20226622.
      View in: PubMed
    15. Escalante CP, Manzullo EF. Cancer-related fatigue: the approach and treatment. J Gen Intern Med. 2009 Nov; 24 Suppl 2:S412-6. PMID: 19838841; PMCID: PMC2763160.
    16. Hwang JP, Holmes HM, Kallen MA, Ensor J, Etchegaray J, Saab R, Arbuckle RB, King KM, Escalante CP. Accuracy of reporting current medications by cancer patients presenting to an emergency center. Support Care Cancer. 2010 Oct; 18(10):1347-54. PMID: 19838868.
      View in: PubMed
    17. Hwang JP, Patlan J, de Achaval S, Escalante CP. Survival in cancer patients after out-of-hospital cardiac arrest. Support Care Cancer. 2010 Jan; 18(1):51-5. PMID: 19350284.
      View in: PubMed
    18. Holmes L, Escalante C, Garrison O, Foldi BX, Ogungbade GO, Essien EJ, Ward D. Testicular cancer incidence trends in the USA (1975-2004): plateau or shifting racial paradigm? Public Health. 2008 Sep; 122(9):862-72. PMID: 18555499; PMCID: PMC2551560.
    19. Escalante CP, Manzullo EF, Lam TP, Ensor JE, Valdres RU, Wang XS. Fatigue and its risk factors in cancer patients who seek emergency care. J Pain Symptom Manage. 2008 Oct; 36(4):358-66. PMID: 18411011.
      View in: PubMed
    20. Elting LS, Lu C, Escalante CP, Giordano SH, Trent JC, Cooksley C, Avritscher EB, Shih YC, Ensor J, Bekele BN, Gralla RJ, Talcott JA, Rolston K. Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia. J Clin Oncol. 2008 Feb 1; 26(4):606-11. PMID: 18235119.
      View in: PubMed
    21. Mock V, Atkinson A, Barsevick AM, Berger AM, Cimprich B, Eisenberger MA, Hinds P, Kaldor P, Otis-Green SA, Piper BF. Cancer-related fatigue. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2007 Nov; 5(10):1054-78. PMID: 18053429.
      View in: PubMed
    22. Liu W, Vyas A, Escalante C, Weiser MA, Wang J, Geraci JM. Results of general internal medicine consultations for diabetes mellitus in 283 cancer patients. Am J Med Sci. 2007 May; 333(5):276-9. PMID: 17505168.
      View in: PubMed
    23. Geraci JM, Tsang W, Valdres RV, Escalante CP. Progressive disease in patients with cancer presenting to an emergency room with acute symptoms predicts short-term mortality. Support Care Cancer. 2006 Oct; 14(10):1038-45. PMID: 16572312.
      View in: PubMed
    24. Geraci JM, Escalante CP, Freeman JL, Goodwin JS. Comorbid disease and cancer: the need for more relevant conceptual models in health services research. J Clin Oncol. 2005 Oct 20; 23(30):7399-404. PMID: 16234509.
      View in: PubMed
    25. Escalante CP, Weiser MA, Lam T, Ho V, Yeung SC. Hypertension in cancer patients seeking acute care: an opportunity to intervene. Am J Med Sci. 2005 Sep; 330(3):120-7. PMID: 16174995.
      View in: PubMed
    26. Kamana M, Escalante C, Mullen CA, Frisbee-Hume S, Rolston KV. Bacterial infections in low-risk, febrile neutropenic patients. Cancer. 2005 Jul 15; 104(2):422-6. PMID: 15937905.
      View in: PubMed
    27. Weiser MA, Cabanillas M, Vu K, Tamm EP, Wallace MJ, Escalante CP, Bresalier RS. Diagnostic evaluation of patients with a high suspicion of malignancy: comorbidities and clinical predictors of cancer. Am J Med Sci. 2005 Jul; 330(1):11-8. PMID: 16020994.
      View in: PubMed
    28. Escalante CP, Weiser MA, Manzullo E, Benjamin R, Rivera E, Lam T, Ho V, Valdres R, Lee EL, Badrina N, Fernandez S, DeJesus Y, Rolston K. Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients. Support Care Cancer. 2004 Sep; 12(9):657-62. PMID: 15185134.
      View in: PubMed
    29. Elting LS, Escalante CP, Cooksley C, Avritscher EB, Kurtin D, Hamblin L, Khosla SG, Rivera E. Outcomes and cost of deep venous thrombosis among patients with cancer. Arch Intern Med. 2004 Aug 9-23; 164(15):1653-61. PMID: 15302635.
      View in: PubMed
    30. Gao S, Escalante C. Venous thromboembolism and malignancy. Expert Rev Anticancer Ther. 2004 Apr; 4(2):303-20. PMID: 15056060.
      View in: PubMed
    31. Weiser MA, Cabanillas ME, Konopleva M, Thomas DA, Pierce SA, Escalante CP, Kantarjian HM, O'Brien SM. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Cancer. 2004 Mar 15; 100(6):1179-85. PMID: 15022284.
      View in: PubMed
    32. Raad I, Hachem R, Hanna H, Afif C, Escalante C, Kantarjian H, Rolston K. Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections. J Antimicrob Chemother. 2004 Apr; 53(4):646-9. PMID: 14998986.
      View in: PubMed
    33. Avritscher EB, Cantor SB, Shih YC, Escalante CP, Rivera E, Elting LS. Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis. Support Care Cancer. 2004 Jul; 12(7):531-6. PMID: 14986076.
      View in: PubMed
    34. Bruera E, Driver L, Barnes EA, Willey J, Shen L, Palmer JL, Escalante C. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol. 2003 Dec 1; 21(23):4439-43. PMID: 14645434.
      View in: PubMed
    35. Raad II, Escalante C, Hachem RY, Hanna HA, Husni R, Afif C, Boktour MR, Whimbey EE, Kontoyiannis D, Jacobson K, Kantarjian H, Levett LM, Rolston KV. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. Cancer. 2003 Sep 1; 98(5):1039-47. PMID: 12942573.
      View in: PubMed
    36. Escalante CP, Manzullo E, Valdres R. A cancer-related fatigue clinic: opportunities and challenges. J Natl Compr Canc Netw. 2003 Jul; 1(3):333-43. PMID: 19761068.
      View in: PubMed
    37. Manzullo E, Liu W, Escalante C. Treatment for cancer-related fatigue: an update. Expert Rev Anticancer Ther. 2003 Feb; 3(1):99-106. PMID: 12597354.
      View in: PubMed
    38. Escalante CP. Treatment of cancer-related fatigue: an update. Support Care Cancer. 2003 Feb; 11(2):79-83. PMID: 12560935.
      View in: PubMed
    39. Manzullo EF, Escalante CP. Research into fatigue. Hematol Oncol Clin North Am. 2002 Jun; 16(3):619-28. PMID: 12170571.
      View in: PubMed
    40. Valdres RU, Escalante C, Manzullo E. Fatigue: a debilitating symptom. Nurs Clin North Am. 2001 Dec; 36(4):685-94, vi. PMID: 11726347.
      View in: PubMed
    41. Escalante CP, Grover T, Johnson BA, Harle M, Guo H, Mendoza TR, Rivera E, Ho V, Lee EL, Cleeland CS. A fatigue clinic in a comprehensive cancer center: design and experiences. Cancer. 2001 Sep 15; 92(6 Suppl):1708-13. PMID: 11598891.
      View in: PubMed
    42. Escalante CP, Martin CG, Elting LS, Price KJ, Manzullo EF, Weiser MA, Harle TS, Cantor SB, Rubenstein EB. Identifying risk factors for imminent death in cancer patients with acute dyspnea. J Pain Symptom Manage. 2000 Nov; 20(5):318-25. PMID: 11068153.
      View in: PubMed
    43. Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C, Donnelly J, Eisenberger MA, Escalante C, Hinds P, Jacobsen PB, Kaldor P, Knight SJ, Peterman A, Piper BF, Rugo H, Sabbatini P, Stahl C. NCCN Practice Guidelines for Cancer-Related Fatigue. Oncology (Williston Park). 2000 Nov; 14(11A):151-61. PMID: 11195408.
      View in: PubMed
    44. Escalante CP, Kurtin D, Rivera E, Elting LS. Severity of illness, outcomes, and resource use in elderly cancer patients with deep venous thrombosis. Clin Appl Thromb Hemost. 2000 Jul; 6(3):175-8. PMID: 10898279.
      View in: PubMed
    45. Weiser MA, O'Brien S, Escalante C, Manzullo E. Tuberculosis meningitis in a patient with acute myelogenous leukemia. Leuk Lymphoma. 1999 Mar; 33(1-2):187-92. PMID: 10194137.
      View in: PubMed
    46. Escalante CP, Martin CG, Elting LS, Rubenstein EB. Medical futility and appropriate medical care in patients whose death is thought to be imminent. Support Care Cancer. 1997 Jul; 5(4):274-80. PMID: 9257423.
      View in: PubMed
    47. Escalante CP, Weiser MA, Finkel K. Hyperphosphatemia associated with phosphorus-containing laxatives in a patient with chronic renal insufficiency. South Med J. 1997 Feb; 90(2):240-2. PMID: 9042182.
      View in: PubMed
    48. Escalante CP, Rubenstein EB, Rolston KV. Outpatient antibiotic therapy for febrile episodes in low-risk neutropenic patients with cancer. Cancer Invest. 1997; 15(3):237-42. PMID: 9171858.
      View in: PubMed
    49. Escalante CP, Martin CG, Elting LS, Cantor SB, Harle TS, Price KJ, Kish SK, Manzullo EF, Rubenstein EB. Dyspnea in cancer patients. Etiology, resource utilization, and survival-implications in a managed care world. Cancer. 1996 Sep 15; 78(6):1314-9. PMID: 8826956.
      View in: PubMed
    50. Escalante CP, Rubenstein EB, Rolston KV. Outpatient antibiotic treatment in low-risk febrile neutropenic cancer patients. Support Care Cancer. 1996 Sep; 4(5):358-63. PMID: 8883229.
      View in: PubMed
    51. Rubenstein EB, Rolston K, Benjamin RS, Loewy J, Escalante C, Manzullo E, Hughes P, Moreland B, Fender A, Kennedy K, et al. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer. 1993 Jun 1; 71(11):3640-6. PMID: 8490912.
      View in: PubMed
    52. Escalante CP. Causes and management of superior vena cava syndrome. Oncology (Williston Park). 1993 Jun; 7(6):61-8; discussion 71-2, 75-7. PMID: 8318360.
      View in: PubMed
    53. Rubenstein EB, Escalante C. Hypertensive crisis. Crit Care Clin. 1989 Jul; 5(3):477-95. PMID: 2670090.
      View in: PubMed
    54. Erratum. Supportive Care in Cancer. 23:2853.
    55. Prospective cohort study of cancer patients diagnosed with incidental venous thromboembolism on routine computed tomography scans. Supportive Care in Cancer. 1-7.
    56. Invasive group a streptococcal infection. Cancer Bulletin. 47:343-346.
    57. Update of targeted therapy-induced hypertension. Current Medical Imaging Reviews. 12:112-120.
    58. Special report. Cancer Control. 5:271-276.
    59. Ongoing Screening and Treatment to Potentially Reduce Tyrosine Kinase Inhibitor-Related Fatigue in Renal Cell Carcinoma. Journal of Pain and Symptom Management. 50:108-117.
    60. Incidence of emergency visits among oncology patients receiving outpatient chemotherapy. Cancer Control. 3:435-441.
    61. The biology of cancer-related fatigue. Supportive Care in Cancer.
    62. Fatigue. 361-373.
    63. Meta-analysis of cardiovascular toxicity risks in cancer patients on selected targeted agents. Supportive Care in Cancer. 1-18.
    ESCALANTE's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description